C.M. Bidwell & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-477
Closed -$222K 551
2020
Q4
$222K Buy
477
+224
+89% +$105K 0.18% 90
2020
Q3
$112K Buy
+253
New +$105K 0.1% 191
2016
Q3
Sell
-115
Closed -$17K 324
2016
Q2
$17K Buy
+115
New +$17K ﹤0.01% 221
2016
Q1
Sell
-33,505
Closed -$4.75M 319
2015
Q4
$4.75M Sell
33,505
-125
-0.4% -$16.7K 1.13% 25
2015
Q3
$4.11M Buy
+33,630
New +$4.38M 1.01% 35

Other funds holding TMO

C.M. Bidwell & Associates's TMO Position: Q1 2021 in Review

C.M. Bidwell & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 477 shares — an estimated $222K sold.

C.M. Bidwell & Associates first reported a position in TMO in Q3 2015 and held it in 5 quarters. The position peaked at $4.75M in Q4 2015. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • C.M. Bidwell & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 477 Thermo Fisher Scientific shares in Q1 2021, an estimated $222K.
  • C.M. Bidwell & Associates first reported a position in Thermo Fisher Scientific in Q3 2015 and held it in 5 quarters.
  • C.M. Bidwell & Associates's Thermo Fisher Scientific position peaked at $4.75M in Q4 2015.
  • 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2021, filed 14 May 2021.